Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Understanding the pillars of financial independence is essential for achieving financial freedom. Learn the key concepts to empower your journey.
16,734 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
A Google-backed study finds only 40% of U.S. workers casually use AI at work, with just 5% AI fluent. The result: big...
Crypto executives and bank regulators left Washington with a shared sense that the work is far from over. The third W...
Archer Aviation sits at a pivotal crossroads as FAA progress updates loom and defense contracts lurk in the wings. Th...
NVIDIA doubles down on its OpenAI investment strategy to secure GPU demand and influence the AI software stack, a mov...
Global markets jump and contracts tighten as trump’s sudden decision hike lifts the tariff rate to 15% worldwide, ove...
Investing in space stocks is no longer a sci‑fi dream. This guide breaks down where will rocket stock likely head in ...
When sentiment hits extreme fear, smart investors pause and plan. This guide explains what the crypto market flashing...
Forward Air’s path to 2025 earnings rests on freight demand, margins, and disciplined cost management. This guide bre...
Nova Measuring Instruments rode an 80% gain in the past year, but a big insider sale prompts question. This guide bre...
Social Security COLAs are meant to protect buying power, but there are three essential truths you need to know. This ...
Retirees eye InfraCap MLP ETF AMZA for a high yield amid volatile markets. This report highlights critical factors re...